Neisseria meningitidis group B correlates of protection and assay standardization—International Meeting Report Emory University, Atlanta, Georgia, United States, 16–17 March 2005

This publication has 87 references indexed in Scilit:

• Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine
  Clinical and Vaccine Immunology, 2005
• Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination
  American Journal of Epidemiology, 2005
• Combined Administration of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine and Conjugated Serogroup C Vaccine Indicated for Prevention of Meningococcal Disease Is Safe and Immunogenic
  Clinical and Vaccine Immunology, 2005
• The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease
  Vaccine, 2005
• Statistical considerations for vaccine immunogenicity trials
  Vaccine, 2004
• Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
  Clinical and Vaccine Immunology, 2003
• Serogroups, Serotypes, Serosubtypes and Antimicrobial Susceptibility of Neisseria meningitidis Isolates in Casablanca, Morocco
  European Journal of Clinical Microbiology & Infectious Diseases, 2002
• Assessment of the Direct Effectiveness of BC Meningococcal Vaccine in Rio de Janeiro, Brazil: A Case-Control Study
  International Journal of Epidemiology, 1995
• Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein conjugate vaccine
  The Journal of Pediatrics, 1987
• A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.
  The Journal of Experimental Medicine, 1986